(Total Views: 764)
Posted On: 05/20/2020 11:47:52 AM
Post# of 158222
“Am I understanding the PR correctly that with a successful 30 patient trial, Mexico may approve Leronlimab for use?”
The mild/moderate trial in the U.S. will most likely be complete and public before the Mexico trial is competed. If the data from mild/moderate trial shows efficacy, the the 30 patient trial in Mexico shows efficacy, I can see Mexico approving the drug for use. Especially if the FDA approved leronlimab for COVID19 following release of the mild/mod COVID19 data.
The mild/moderate trial in the U.S. will most likely be complete and public before the Mexico trial is competed. If the data from mild/moderate trial shows efficacy, the the 30 patient trial in Mexico shows efficacy, I can see Mexico approving the drug for use. Especially if the FDA approved leronlimab for COVID19 following release of the mild/mod COVID19 data.
(0)
(0)
